Welcome to our dedicated page for EXDID news (Ticker: EXDID), a resource for investors and traders seeking the latest updates and insights on EXDID stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect EXDID's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of EXDID's position in the market.
Panacea Life Sciences Holdings, trading under the symbol EXDID, will change its ticker symbol to PLSH on November 26, 2021. This change reflects the company's commitment to natural health alternatives to conventional pharmaceuticals. Founded in 2017, Panacea produces a wide range of cannabinoid products including gummies, oils, and topicals, emphasizing high-quality standards in their operations. The company operates a 51,000 sq. ft. cGMP certified facility and has attracted significant investments totaling $34 million to date.
Panacea Life Sciences (OTCQB: EXDID) has launched four new products in its PANA Beauty skincare line, aiming to capture a share of the expanding CBD skincare market, projected to reach USD 1.3 billion by 2026 with a 33% CAGR. Developed in collaboration with dermatologist Dr. Paul Dean, the products include a CBD Soothing Eye Therapy serum, Full Body CBD Moisture Therapy lotion, Skin Clearing CBD Gel, and CBD Regenerating Facial Cream. The new line caters to rising consumer demand for all-natural, clean ingredient products, positioning Panacea for potential revenue growth.
Exactus, Inc. (OTCQB:EXDI), soon to be Panacea Life Sciences, Inc. (OTCQB:PLSH), is leveraging the resurgence of passenger traffic at Denver International Airport to promote its premium CBD products, with nearly 25 million travelers in the first half of 2021. Panacea has established two kiosk locations in the airport, making it the first company to offer CBD products directly to passengers. The range includes topical CBD items for pain relief, adhering to hemp regulations. Founded in 2017, Panacea has attracted $20 million in investments, continuing to grow in the evolving CBD market.
Exactus, Inc. (OTCQB:EXDID) has rebranded as Panacea Life Sciences Holdings, Inc. effective October 28, 2021, following FINRA approval. A 1-for-28 reverse stock split will also take place. The temporary trading symbol is EXDID, transitioning to PLSH after twenty business days. This change coincides with the acquisition of Panacea Life Sciences, Inc., which has raised $20 million in investments and focuses on producing legal, trace THC, hemp-derived cannabinoid products. CEO Leslie Buttorff emphasized the importance of this rebranding for enhancing shareholder value.
